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Research
Between 800,000 and 1.2 million buildings in
the United States may be associated with
building-related illnesses, and thus, between 30
and 70 million workers are exposed to poten-
tially unhealthy working conditions (Kreiss
1990; Woods 1989). Mixtures of volatile
organic compounds (VOCs) and ozone (O3)
are prominent pollutants in indoor environ-
ments (Fan et al. 2003). In some cases, VOCs
measured in office buildings are associated
with complaints of mucosal irritation and non-
speciﬁc symptoms such as headache (Hodgson
et al. 1991; Ten Brinke et al. 1998). Further-
more, healthy men and women intentionally
exposed to similar mixtures of VOCs report
increased symptoms of eye, nose, and throat
irritation and reduced air quality ratings relative
to clean air conditions (Hudnell et al. 1992;
Prah et al. 1998). The number of symptoms
reported in controlled exposure studies, how-
ever, are relatively few and of mild intensity
compared with the ongoing complaints of
ofﬁce workers (Apter et al. 1994; Mendell and
Smith 1990; Nordstrom et al. 1994; Zweers
et al. 1992). Thus, some investigators suggest
that when O3 reacts with VOCs in building
environments, secondary products including
ultraﬁne particles (particulate matter with aero-
dynamic diameter < 0.1 µm)may mediate the
more substantial effects found in ofﬁces (Bako-
Biro et al. 2004; Fan et al. 2003; Rohr et al.
2002; Weschler and Shields 2000; Wolkoff
and Nielsen 2001). Our study assesses a
selected suite of subjective and objective mark-
ers in response to the following exposure condi-
tions: VOCs, VOCs + O3, and ambient air
with a 1-min spike of VOCs [masked clean air
(MCA)]. We hypothesized that exposure to
VOCs or VOCs + O3 would result in greater
symptom severity, compromised neurobehav-
ioral performance, reduced lung function, and
increased salivary cortisol relative to the MCA
exposure (hypothesis 1: exposure main effect).
Gender and psychological stress also con-
tribute to health complaints in buildings
(Crawford and Bolas 1996; Hodgson 1995;
Mendell 1993). For example, Bachmann and
Myers (1995) found gender and psychological
symptoms to be signiﬁcant predictors of symp-
toms in two problem and one nonproblem
building. Temperature, uncomfortable humid-
ity, and reported odors, however, were also
associated with symptoms in the buildings
investigated. Women consistently report the
highest prevalence of symptoms (Skov et al.
1989; Stenberg and Wall 1995), although
external psychological stress (work load and
control) is also associated with complaints
(Norback et al. 1990; Ryan and Morrow
1992). Therefore, we chose to include only
women in our study and to expose subjects to
chemical mixtures with and without psycholog-
ical stress. We hypothesized that subjects would
report signiﬁcantly greater symptom severity
and would show a greater cortisol response
when exposed to VOCs or VOCs + O3 with
psychological stress compared with these expo-
sure conditions without stress or to the MCA
condition with or without psychological stress
(hypothesis 2: exposure × stress interaction).
In summary, indoor environmental quality
is affected by numerous factors, including bio-
logical, chemical, and particulate pollutants;
temperature and humidity; quality of the heat-
ing, ventilation, and air conditioning system;
noise; light; and odor (Mendell and Heath
2005). Our present study assessed the interac-
tion of chemical pollutants and psychological
stress on subjective (i.e., symptoms) and
objective (i.e., cortisol, lung function, neu-
robehavioral performance) indicators of health
effects, while holding temperature, humidity,
noise, and light constant. Furthermore, our
study added an untested exposure dimension
created by combining VOCs with O3, shown
in previous studies to produce a suite of irri-
tating gas and condensed-phase products (Fan
et al. 2003).
Materials and Methods
Subjects
One hundred thirty healthy, nonsmoking
women, who were on average 27.2 years of age
(SD = 8.0) with 15.2 (SD = 1.9) years of edu-
cation, were recruited via advertisements in
local newspapers. The ethnic composition of
the sample was as follows: Caucasian, 56%
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In our present study we tested the health effects among women of controlled exposures to volatile
organic compounds (VOCs), with and without ozone (O3), and psychological stress. Each subject
was exposed to the following three conditions at 1-week intervals (within-subject factor): VOCs
(26 mg/m3), VOCs + O3 (26 mg/m3 + 40 ppb), and ambient air with a 1-min spike of VOCs
(2.5 mg/m3). As a between-subjects factor, half the subjects were randomly assigned to perform a
stressor. Subjects were 130 healthy women (mean age, 27.2 years; mean education, 15.2 years).
Health effects measured before, during, and after each 140-min exposure included symptoms,
neurobehavioral performance, salivary cortisol, and lung function. Mixing VOCs with O3 was
shown to produce irritating compounds including aldehydes, hydrogen peroxide, organic acids,
secondary organic aerosols, and ultraﬁne particles (particulate matter with aerodynamic diameter
< 0.1 µm). Exposure to VOCs with and without O3 did not result in significant subjective or
objective health effects. Psychological stress signiﬁcantly increased salivary cortisol and symptoms
of anxiety regardless of exposure condition. Neither lung function nor neurobehavioral perfor-
mance was compromised by exposure to VOCs or VOCs + O3. Although numerous epidemiologic
studies suggest that symptoms are signiﬁcantly increased among workers in buildings with poor
ventilation and mixtures of VOCs, our acute exposure study was not consistent with these epi-
demiologic findings. Stress appears to be a more significant factor than chemical exposures in
affecting some of the health end points measured in our present study. Key words: building-related
illness, lung function, neurobehavioral, ozone, stress, symptoms, volatile organic compounds.
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http://dx.doi.org/ [Online 21 July 2005](n = 73); black, 10% (n = 13); Hispanic, 8%
(n = 10); Asian, 20% (n = 26); other, 6%
(n = 8). Subjects completed a medical history,
physical examination, and standard clinical
blood chemistry to rule out previous signiﬁcant
occupational exposure to chemicals and the
following health conditions: neurologic disease
or brain injury, stroke or cardiovascular disease,
serious pulmonary disease including asthma,
liver or kidney disease, serious gastrointestinal
disorders, known endocrine disease, pregnancy
or lactation, and major psychiatric conditions,
including psychoses, bipolar disorder, alco-
holism or drug abuse, and multiple chemical
sensitivity with signiﬁcant illness behavior or
disability. Three hundred forty-one individuals
were screened for the study. Fifty-four were
excluded at the telephone screening because of
medical conditions, 74 never came in for their
appointed physical examination, 40 declined
to participate after the physical examination,
19 were excluded for medical conditions dis-
covered at the physical examination, 4 dropped
out after their first exposure, and 6 dropped
out after their second exposure (n = 197).
Fourteen of the 144 subjects who completed
the study were pilot subjects whose data were
not included in the analysis.
Dependent Measures
Symptom questionnaire. Subjects rated each
symptom on a ratio scale from 0 (barely
detectable/no sensation) to 100 (strongest
imaginable) (Green et al. 1996). We chose
symptoms based on previous literature assess-
ing the health effects of indoor air mixtures
(Molhave et al. 1986; Prah et al. 1998). These
symptoms included the cognitive and physical
effects expected of VOC mixtures (Hudnell
et al. 1992; Molhave et al. 1986), anxiety
symptoms associated with the odor of expo-
sure, eye irritation, upper respiratory and lower
respiratory symptoms associated with O3 and
the secondary products generated from the
reactions of O3 with VOCs (Fan et al. 2003),
and somatic symptoms not typically associated
with VOC mixtures (Appendix 1) (Dalton
et al. 1997).
Neurobehavioral. This computerized
divided-attention test of cognitive performance,
performance on-line (POL) (Mills et al. 1996)
offered ﬁve different levels of complexity. The
test was validated in alcohol dosing trials and
was developed explicitly for use in repeated-
measures studies of alcohol and drug effects.
POL included a central task in which the sub-
ject was presented with two lanes of traffic,
divided by a double yellow line. Four condi-
tions of “headlights” and “tail lights” appeared
on any one trial. The subject was instructed to
press the space bar only when a “safe” condition
(i.e., left lane, white headlights, and right lane,
red tail lights) existed. The peripheral task
required the subject to respond with one of four
arrow keys (up, down, left, right) in the direc-
tion of the critical stimulus (red octagon among
other shapes). Task difficulty increased by
increasing the number of distracting stimuli in
the peripheral display to a random assortment
of different colored circles, squares, and trian-
gles. For the divided-attention display, the sub-
ject responded to both central and peripheral
critical stimuli. After practice, 10 trials of
45 displays were presented at the most complex
level. A composite performance score, com-
posed of seven component scores, including
hits, misses, false positives, response latency,
and responses to targets at varying levels of
visual angle, was the performance variable
measured (Badiani et al. 1995).
Cortisol assays. An extensive literature
documents the signiﬁcant (r ≥ 0.90) associa-
tion between salivary and plasma cortisol
(Kirschbaum and Hellhammer 1989, 1994).
Salivary ﬂow, which may be affected by anxi-
ety, is not documented to affect the concen-
tration of salivary cortisol (Dirks et al. 1988;
Kahn et al. 1988), although circadian rhythm
affects cortisol production (Walker et al.
1984). Thus, we tested subjects at the same
time of day to control for the well-known
circadian effect on cortisol production.
Kirschbaum and Hellhammer (1989, 1994)
also reported that, although a highly signifi-
cant correlation is shown between salivary
and plasma cortisol, absolute values vary sig-
nificantly. However, in our study, we evalu-
ated relative change scores rather than
absolute values. Because hormonal fluctua-
tions also affect cortisol levels, we measured
salivary estradiol at baseline before each expo-
sure session to account for any effects of ovu-
lation on salivary cortisol.
Consistent with Kirschbaum and
Helhammer (1989), we collected samples using
the Salivette (Sarstedt Inc., Rommelsdorf,
Germany) method. We asked the subject to
chew on a cotton swab for 60 sec, then
place the swab into a Salivette holder and afﬁx
the cap. The samples were centrifuged at
3,000 rpm for 10 min, which produced
0.5–1 mL of saliva. The saliva was frozen.
Samples were analyzed, blind to exposure con-
dition and subject characteristics, in one of the
co-investigators’ laboratories (J.O.). Samples
were run in duplicate, and equal numbers
of samples from each group were run in the
same assays.
Pulmonary function test. With the sub-
jects in standing position with nose clips
attached, spirometry was performed using a
Multispiro SX spirometry system (Creative
Biomedics, Inc., San Clemente, CA) that was
calibrated daily. We used the highest value for
each parameter from any one of three repro-
ducible tracings before exposure for compari-
son with the highest value for each parameter
postexposure. Forced vital capacity (FVC),
forced expiratory volume in 1 sec (FEV1), and
forced expiratory ﬂow 5–75% (FEF25–75) were
parameters of interest.
Independent Variables
Public speaking task stressor. After a 4-min
silent preparation period, subjects constructed
and delivered a 4-min speech on the following
controversial scenarios: a) construct a presenta-
tion on the causes of gray hair from a Reader’s
Digest article; b) present a position on whether
homosexual men should be allowed in the mili-
tary and be given special civil rights protection;
c) defend herself against a shoplifting charge in
front of three authority figures (al’Absi et al.
1997). In a direct comparison al’Absi et al.
(1997) demonstrated that these three different
topics caused a similar level of stress (cortisol
response). We randomized the order of the
three scenarios across subjects such that each
subject delivered a speech on a different topic in
each of her three exposure conditions. After the
preparation period, subjects were told by the
experimenter to stand, face the video camera,
and begin giving the speech. To enhance the
stressfulness of the procedure, we told each sub-
ject that the research technician was evaluating
the speech as it was given and that three staff
members would evaluate a videotape of the
speech later; the subject was promised an addi-
tional stipend of $10 if she performed well.
After completion of the three experimental ses-
sions, all subjects received the added stipend
regardless of performance.
Controlled environment facility and expo-
sure generation. The Environmental and
Occupational Health Sciences Institute
Controlled Environment Facility (CEF) is a
stainless steel room 2.2 m ×high ×4.1 m wide ×
2.7 m deep with a total volume of 25 m3. The
air supply is treated in a series of conditioning
processes, which include air cooling/heating,
humidiﬁcation/dehumidiﬁcation, and ﬁltration
through carbon and high-efﬁciency particulate
air (HEPA) ﬁlters. All parameter controls are
computer interfaced to maintain constant con-
ditions in the CEF. To simulate a typically ven-
tilated ofﬁce building and to allow sufﬁcient
time for the formation of O3–VOC reaction
products, the air ﬂow rate through the facility
was controlled at 1.8 ± 0.2 air changes/hr for all
the exposures conducted in this study. The air
supply enters the facility through two diffusers
in the ceiling and exits through the perforated
stainless steel ﬂoor to the exhaust vents. Small
brushless fans (to prevent unwanted particle
generation from brush degradation) were used
in the CEF to ensure that the air was well
mixed. During exposure sessions, the relative
humidity and temperature were controlled to a
range of between 24 and 49% and 73–82°F
(23–28°C), respectively. A Teflon partition
separated the subjects’ work stations, which
were equipped with a computer and typing
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tion allowed exposure of two subjects at a time.
The technician communicated separately with
each subject through headphones and could
view subjects at all times through a two-way
window. For subject safety, an electrocardio-
gram (ECG) signal was collected using dispos-
able electrodes and sampled at 996 Hz through
the Flexcomp Biomonitoring system 1.51 B
(Thought Technology Ltd., Montreal, Quebec,
Canada). This allowed continuous monitoring
of heart rate during the exposure period.
The composition and relative weight of the
VOC mixture used were similar to those in
previous indoor air studies (Kjaergaard et al.
1991; Molhave et al. 1986; Otto et al. 1992)
and are reported in Table 1 (Fan et al. 2003).
d-Limonene, the most frequently identiﬁed ter-
pene in indoor air, was also added to the mix-
ture. A ﬂask containing the liquid mixture of
these 23 compounds was heated to 250°C by a
hot plate, ﬂash evaporated, and injected into
the clean air stream that delivered the VOC
mixture into the CEF. Constant concentrations
of chemical compounds can be maintained in
the CEF by injection of the chemicals continu-
ously into the air supply, which ﬂows through
the CEF without recirculation. The desired
concentration of VOCs in the indoor environ-
ment was achieved by adjusting the ﬂow rate of
the delivering air using a mass ﬂow controller.
Total VOC concentration in the air of 
the indoor environment was approximately
26 mg/m3, with the concentration of each
compound below the threshold limit value
recommended for occupational exposure by 
the American Conference of Governmental
Industrial Hygienists (1992). MCA was
generated by introducing a 1-min spike of the
VOC mixture at approximately 10% of the
exposure concentration for the VOC exposure
condition. The maximum total VOC concen-
tration in the CEF during the MCA condition
was approximately 2.5 mg/m3. Given the air
exchange rate used in the experiments, it took
about 90 min for the masking concentration to
decay to 0.25 mg/m3.
The background O3 concentration is
< 3 ppb in the CEF. O3 generated in situ by
an O3 generator was delivered into the CEF
and was maintained at a steady-state concen-
tration of 40 ppb. This was consistent with
the intention to examine the effect of products
of O3–VOC reactions rather than O3 itself.
Table 2 compares the concentrations of by-
products generated in the VOC + O3 condi-
tion relative to the VOC condition. Exposure
generation and characterization were described
in detail in a previous publication (Fan et al.
2003).
Procedures
Before receiving a complete physical examina-
tion, including a medical history review and
routine blood chemistries, subjects who met
inclusion criteria gave written informed consent
according to the University of Medicine and
Dentistry of New Jersey–Robert Wood Johnson
Medical School Institutional Review Board. To
reduce practice and novelty effects, subjects were
shown the CEF and trained to perform the fol-
lowing procedures: symptom questionnaire,
speech and neurobehavioral tasks, salivary sam-
pling for cortisol and estradiol, nasal lavage, and
spirometry. Subjects were randomly assigned to
the order of exposure conditions, half with and
half without the stressor. Subjects were told dur-
ing informed consent that they may be asked to
perform a public speaking task. They were not
told whether they would be performing the task
before any exposure session. Thus, subjects were
blind to the stress condition. Neither the subject
nor the research technicians were told exposure
conditions.
Each experimental session was 3 hr in dura-
tion and occurred in the morning. Subjects were
asked not to use caffeine or alcohol on the day
before and on the day of the testing session.
Subjects also could not have an active upper res-
piratory illness (either infection or allergy) or use
medication for allergies or other respiratory
conditions for 1-week before each exposure
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Table 1. The mixture of VOCs.
Relative Concentration
No. Compound weight (mg/m3)
1 n-Butylacetate 10 8.25
2 p-Xylene 10 8.25
3 n-Butanol 1 0.825
4 n-Decane 1 0.825
5 1-Decene 1 0.825
6 1,1-Dichloroethane 1 0.825
7 d-Limonene 1 0.825
8 Ethylbenzene 1 0.825
9 Ethoxyethylacetate 1 0.825
10 n-Hexanal 1 0.825
11 n-Hexane 1 0.825
12 n-Nonane 1 0.825
13 α-Pinene 1 0.825
14 2-Butanone 0.1 0.083
15 Cyclohexane 0.1 0.083
16 3-Methyl-2-butanone 0.1 0.083
17 4-Methyl-2-pentanone 0.1 0.083
18 n-Pentanal 0.1 0.083
19 Isopropanol 0.1 0.083
20 n-Propylbenzene 0.1 0.083
21 1,2,4-Trimethylbenzene 0.1 0.083
22 n-Undecane 0.1 0.083
23 1-Octene 0.01 0.008
Total 26.330
Table 2. Summary of products observed during different exposure conditions.
Ultraﬁne
particle number Particle mass Hydrogen
Exposure concentration concentration Formaldehyde p-Tolualdehyde Glyoxal peroxide
conditions (particles/cm3)a (µg/m3)b (µg/m3)b (µg/m3)b (µg/m3)b (ppb)a,c
MCA NAd < 5 7 ND ND NAd
VOCs (23 VOCs) 2,500 3–7 13 ND ND 0.3
VOCs + O3(O3+ 23 VOCs) 46,000 140 40 6.2 4.6 1.9
ND, not detected.
aTwo-hour average concentration. bFour-hour average concentration. cIncludes hydrogen peroxide and organic
hydroperoxides. dNot measured but expected to be the same or lower than the 23 VOC-only condition.
Figure 1. Time line for experimental procedure. Abbreviations: Cort1, cortisol collection at minute 15; Cort2,
cortisol collection at minute 90; Cort3, cortisol collection at minute 110; Cort 4, cortisol collection at minute 130;
Neuro1, neurobehavioral task (POL) at minute 15; Neuro2, Neurobehavioral task (POL) at minute 60; Neuro3,
neurobehavioral task (POL) at minute 140; Neuro4, neurobehavioral task (POL) at 5 min postexposure; Sym1,
symptom questionnaire at baseline; Sym2, symptom questionnaire at minute 15; Sym3, symptom questionnaire
at minute 60; Sym4, symptom questionnaire at minute 90; Sym5, symptom questionnaire at minute 110; Sym6,
symptom questionnaire at minute 130; Sym7, symptom questionnaire at 5 min postexposure.
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180session. These conditions were queried by a
nurse before participation on each day of expo-
sure, and subjects were rescheduled if necessary.
Two subjects were tested at the same time.
On the day of the first exposure session, a
pregnancy test was given. Under typical room
air conditions, a spirogram was performed in
our clinical center before and after each expo-
sure session. Subjects also completed the
symptom questionnaire, practiced the POL,
and performed baseline nasal lavage and
salivary sampling for estradiol analysis in our
clinical center.
We escorted subjects to the CEF, where
they were seated at a table, had ECG sensors
attached, and were given a pair of headphones
used to communicate instructions for adminis-
tration of questionnaires and tasks by the
research technician. We gave each subject a
loose-leaf binder with dividers to separate each
of the questionnaires and tasks to be com-
pleted. Baseline measures before exposure were
collected while the subject sat quietly with ﬁl-
tered room air, after which the exposure was
administered for 140 min (Figure 1). During
the initial 20 min of the exposure, subjects read
quietly. We administered a 10-min vigilance
task to maintain a consistent level of alertness
across subjects before introduction of the psy-
chological stressor (Jennings et al. 1992). In
this simple color detection task, we instructed
subjects to count bars that appeared periodi-
cally on a computer screen. After completion
of the task, we asked subjects the number of
bars counted. Subjects then completed either
the public speaking task or simple arithmetic.
While subjects performed the simple arith-
metic task, they heard classical music through
their headphones to screen out the other sub-
ject’s voice. After this period, all subjects typed
a standard text for 10 min. A different text was
used for each experimental session. As indi-
cated in Figure 1, subjects completed question-
naires, collected salivary samples for cortisol
analysis, and performed the neurobehavioral
task during clean air baseline and the exposure
period. Immediately after exposure we escorted
subjects to our clinical center, where they per-
formed postexposure spirometry, nasal lavage,
the neurobehavioral task, and completed a
questionnaires (Figure 1).
Statistical Analysis
Symptoms. We analyzed the effects of exposure,
stress, and time on both presence/absence of
symptoms and symptom severity. For pres-
ence/absence, if a subject reported any symp-
tom at all, then a “yes” was recorded; otherwise,
a “no” was recorded. For presence/absence, a
hierarchical logistic regression (Davidian and
Giltinan 1995; McCulloch and Searle 2000)
modeled the log-odds of no symptoms being
reported for assessment at minute 15 (baseline)
through minute 185 (after removal from expo-
sure facility). For symptom severity, data were
analyzed using a hierarchical Poisson regression
model. In both cases generalized estimating
equations were used that accounted for correla-
tions between repeated measurements on the
same individual (Liang and Zeger 1986). Tests
of the exposure effects were conducted using
type 3 score tests (Liang and Zeger 1986) of the
interaction between exposure and time. Time
was entered into the model as a categorical
variable. We used contrasts to test whether
individual changes in symptoms from baseline
(minute 15) to each subsequent time point dif-
fered between exposures. The mean odds of
reporting symptoms or the mean severity of
symptoms at baseline was assumed to be the
same for all three exposures. This analysis was
first completed for the total symptoms and
then for each classiﬁcation of symptoms: VOC
physical, VOC cognitive, eye irritation, anxi-
ety, upper respiratory, lower respiratory, and
somatic control symptoms. Results were based
on the 130 subjects who received all three
exposures, including the MCA condition.
Uncorrected α-values are reported, with the
α level after Bonferroni correction noted for
each group of multiple comparisons.
Cortisol analyses. Cortisol is normally ele-
vated during ovulation, potentially attenuating
a woman’s cortisol response to a stressor at that
time. Therefore, cortisol data were analyzed
both with and without data from any speciﬁc
exposure session in which the subject’s estra-
diol level was ≥ 5 ng/mL. Based on this cutoff,
13 of the 130 (10%) subjects were ovulating
during their MCA exposure, 13 of 130 (10%)
were ovulating during the VOC exposure, and
15 of 130 (11.5%) were ovulating during the
VOC + O3 exposure. On comparison of the
cortisol data analyses with and without ovula-
tion sessions, no differences in outcome were
noted. Therefore, sessions in which subjects
were ovulating were included in the final
analyses of cortisol.
Given the continuous response, SAS
PROC MIXED (SAS Institute Inc. 1999) was
used to analyze the fixed-factor effects. The
cortisol response was right skewed and there-
fore, for the linear models, was transformed
using a square root transformation to better
satisfy the normality assumption required for
the mixed linear model.
Neurobehavioral performance and lung
function. A mixed linear model was used to
test the effect of exposure on the composite
score from the neurobehavioral task and on
indicators of lung function.
Results
Hypothesis 1: Exposure Main Effect
Symptoms. After controlling for baseline symp-
toms (minute 15), the overall test of the expo-
sure main effect on total symptom severity did
not conﬁrm hypothesis 1 (Figure 2). However,
marginal effects for presence/absence of 
the subscales of VOC physical symptoms
(chi squared = 18.01; df = 10; p < 0.05) and
severity of lower respiratory symptoms
(chi squared = 16.92; df = 10; p < 0.08) were
observed; no effects were observed for the other
categories of symptoms.
Neurobehavioral performance, salivary
cortisol, and lung function. There was no sig-
niﬁcant main effect of exposure on neurobe-
havioral performance (F = 1.00, df = 6, 387;
p = 0.4273), salivary cortisol (F = 0.40; df = 6,
316; p = 0.888), or lung function (data not
shown for neurobehavioral or cortisol meas-
ures; see Table 3 for lung function).
Hypothesis 2: Exposure × Stressor
Interaction
Symptoms. Hypothesis 2 was not conﬁrmed for
presence/absence or for total symptom severity.
However, regardless of exposure condition, sub-
jects who were in the stress condition reported
signiﬁcantly greater severity on the anxiety sub-
scale (chi squared = 22.73; df = 5; p < 0.0004)
than those who were not. Speciﬁcally, relative
to baseline either before (minute 15) or after
exposure onset (minutes 60 and 90), symptoms
of anxiety were signiﬁcantly more severe after
the stressor at minutes 110 and 125 (Figure 3).
No other symptom subscale was signiﬁcantly
affected by stress or by the exposure × stressor
interaction.
Salivary cortisol. The hypothesized interac-
tion effect of exposure × stress on cortisol was
not signiﬁcant, but the main effect of stress on
Volatile organics, ozone, and stress
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Figure 2. Total mean symptom severity at each time
point across exposures.
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Table 3. Spirometry changes after exposures to MCA, VOCs, and VOCs + O3 (mean difference ± SD; n = 130).
MCA VOCs VOCs ± O3 p-Value
Change in FEV1 (mL) –50.46 ± 174.02 6.15 ± 176.56 –25.30 ± 210.33 0.05
Change in FVC (mL) –71.54 ± 189.22 –42.62 ± 184.40 –60.38 ± 237.11 0.52
Change in FEF25–75 (L/sec) –0.00 ± 0.41 0.51 ± 3.63 0.09 ± 0.53 0.12
Difference is the post-minus preexposure score. Bonferroni correction: p < 0.02.cortisol was signiﬁcant (F = 4.90; df = 3, 347;
p = 0.0024). The signiﬁcance of the main effect
of stress was due to changes in cortisol levels
from before the stressor (minute 90) to after the
stressor (minute 125) (t = 4.00; p < 0.0001).
When examining changes from minutes 110 to
125, on average, the cortisol levels decreased
(from 0.178 to 0.154) for the no-stressor
condition and increased slightly (from 0.140
to 0.147) for thestressor condition (t = 3.63;
p = 0.0003) (Figure 4).
Discussion
The most striking result of our study was the
lack of signiﬁcant subjective or objective health
effects from exposure to mixtures of VOCs
both with and without O3, despite signiﬁcant
differences in the chemical composition of 
the air for the three conditions (Table 2).
Numerous epidemiologic studies suggest that
symptoms are significantly increased among
workers in buildings with poor ventilation and
mixtures of VOCs (Mendell 1993; Mendell
et al. 2002; Sieber et al. 1996), many of which
likely contain low levels of O3. Our present
controlled acute exposure to similar chemical
mixtures in young women, however, failed to
support these epidemiologic ﬁndings. Relative
to ambient air masked with a pulse of VOCs,
neither the VOC nor the VOC + O3 exposures
caused signiﬁcantly increased symptom reports,
changes in cortisol, reduced neurobehavioral
performance, or changes in lung function.
Subjects were more likely to report some VOC
physical symptoms in the VOC and VOC +
O3 conditions relative to the MCA condition.
However, these effects were of marginal signiﬁ-
cance and became nonsigniﬁcant with appro-
priate correction for multiple comparisons.
Conversely, although stress did not exacerbate
exposure effects, stress signiﬁcantly increased
symptoms of anxiety. The effect of stress was
further validated by the signiﬁcant difference in
cortisol for those who received the stressor
relative to subjects who did not.
There was a marginal (p < 0.08) increase in
severity, but not incidence, of lower respiratory
symptoms with the VOC and VOC + O3
exposure. However, there were no signiﬁcant
changes in the lung function parameters attrib-
utable either to the VOC or VOC + O3 expo-
sure. This is consistent with work showing
increased lower respiratory symptoms at
50 mg/m3 but not at 25 mg/m3 of VOCs
alone, but no change in spirometry or increase
in inﬂammatory mediators from induced spu-
tum at either VOC concentration, again with-
out O3 (Pappas et al. 2000). Although rodent
bioassays had indicated that relatively higher
concentrations of limonene–O3 oxidation
products were irritating to the respiratory tract,
at our exposure concentrations we did not see
an effect on lung function and only a marginal
effect on symptoms (Rohr et al. 2002; Wilkins
et al. 2001). Indicators of nasal inﬂammation
were also negative for our exposures (Laumbach
et al., in press). In contrast to our present ﬁnd-
ings, Kleno and Wolkoff (2004) reported
increases in eye blink frequency among a small
number of subjects with eye exposure only to
limonene oxidation products and nitrate radi-
cals relative to clean air. Although we did not
measure eye blink frequency, symptoms of eye
irritation were not signiﬁcantly greater in the
VOC + O3 condition.
Our present findings regarding neuro-
behavioral performance are consistent with
those of Otto et al. (1992), who reported no
changes in neurobehavioral performance
among subjects exposed to a similar mixture of
23 VOCs relative to clean air. However, the
research group from the Technical University
of Denmark reported several studies in which
subjects were exposed to off-gassing from a
20-year-old carpet and showed reductions in
productivity on tasks that simulate ofﬁce work
(typing, calculations) (Wargocki et al. 1999,
2000a). Although the total VOCs were of
similar concentrations between the exposure
conditions with and without the carpet
(~ 2.34 ppm), the composition of the chemical
mixture differed substantially between the two
conditions, and likely contained unidentiﬁed
compounds associated with emissions from the
carpet. In contrast to the negative ﬁndings in
our present study, Wargocki et al. (1999,
2000a) also reported more symptoms (head-
ache) and slower typing speed in response to
the condition with the old carpet (polluted
condition). Because the total VOC concentra-
tion (2.35 ppm) was less than in our present
study, symptom and performance differences
could be ascribed to differences in the chemical
composition, to unspecified biological com-
ponents, or to differences in task demands.
Neither acetone nor acetic acid was present in
the VOC mixture used in our present study
(only small amounts were produced from the
O3 and VOC reactions), but such a specific
chemical effect seems unlikely. Wargocki et al.
(1999, 2000b) also suggested that simulated
work tasks (typing, calculations) performed
over a longer period of time (265 min) than in
our present study were more sensitive to the
effects of poor air quality than are standard
neurobehavioral tasks. Thus, although the
POL was given for approximately 20 min on
two occasions during exposure, this did not
require the sustained effort needed to perform
continuous typing for 47 min on two occa-
sions as in the Wargocki et al. (1999, 2000b)
studies. However, the use of an old carpet as an
exposure was ultimately not comparable with
the present speciﬁc VOC mixture.
Although some increased symptoms were
observed in previous controlled exposures using
similar “indoor air” mixtures (Hudnell et al.
1992; Prah et al. 1998), actually only a few out
of many symptoms assessed in those studies
were signiﬁcantly increased. A careful examina-
tion of those symptoms exacerbated by expo-
sure reveals some consistency with our present
ﬁndings. Prah et al. (1998) reported that rela-
tive to clean air, mixtures of VOCs increased
ratings of nasal irritation, odor intensity, and air
quality but not health (cough, sore throat) and
cognitive symptoms (memory loss, dizziness).
Similarly comparing responses of a VOC mix-
ture with clean air, Hudnell et al. (1992)
reported signiﬁcantly reduced air quality ratings
and increased odor level, but they also reported
increased symptoms of headache, eye irritation,
drowsiness, and throat irritation. However,
Hudnell et al. (1992) did not control for multi-
ple statistical comparisons among the individual
tests of 22 symptoms (p-value set at < 0.05).
Furthermore, no previous indoor air study has
“masked” the clean air condition to control for
the effects of odor on symptoms. Several studies
suggest that when subjects rate air contami-
nated with various combinations of limonene,
O3, and ofﬁce products (paper), they report dis-
satisfaction with air quality (Knudsen et al.
2002; Tamas et al., in press). However, these
studies did not measure health symptoms.
To further clarify our findings, we con-
ducted power calculations to estimate the size
of the effect that would be necessary to detect
Fiedler et al.
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Figure 3. Mean anxiety symptom severity at each
time point across exposures stress versus no stress.
Bonferroni correction: p < 0.003. Time point compari-
son for anxiety symptom sensitivity is as follows:
change from minute 15 (baseline) to minute 110
(poststress), χ2 = 15.17 (p < 0.0001); change from
minute 60 (after exposure onset) to minute 110 (post-
stress), χ2 = 12.52 (p < 0.0004); change from minute 90
(prestress) to minute 110 (poststress), χ2 = 30.16 (p <
0.0001); change from minute 110 to minute 125, χ2 =
22.29 (p < 0.0001); change from minute 110 to
minute 185 (poststress), χ2= 11.64 (p< 0.0006).
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Figure 4. Cortisol over time for stress versus no
stress regardless of exposure.
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Based on 130 subjects receiving all three expo-
sures, we calculated the minimum actual
symptom difference between the VOC and
VOC + O3 exposures and the MCA exposure
that would be needed to attain a power of
90%. In these power calculations, we assumed
that the size of the exposure effect, relative to
MCA, was the same for VOCs and VOCs +
O3. To simplify the calculations, we used
changes from baseline as the response variable
in a repeated-measures analysis of variance.
We calculated the variance components for
each response and time point from the exist-
ing data. To account for multiple testing, the
Bonferroni corrected significance level was
used corresponding to the level used for test-
ing in our present study.
The results indicate that in all cases, mini-
mum average increases of between 0.6 and
3.0 points in the average score for each cate-
gory of symptoms would have to exist in order
to detect a difference with a power of 90%
(Table 4). With symptom severity scored on a
scale of 0 to 100, this indicates that very small
changes were detectable with the sample size
used in our study.
We performed similar power calculations
for the main effect of exposure on neuro-
behavioral performance, cortisol, and lung
function. The minimum detectable difference
in neurobehavioral performance between the
VOC, VOC + O3, and MCA conditions for a
power of 90% was calculated at 1.30 using 
a 0.05 signiﬁcance level. Because of a within-
session learning effect, the MCA exposure
resulted in a mean increase from baseline (base-
line mean = 32.72; SD = 9.1) of 2.10 points
on the neurobehavioral task. With 130 subjects
we could detect a relative reduction of
1.30 points resulting in 0.80 point improve-
ment for the VOC or VOC + O3 exposure
conditions (i.e., 2.10 – 1.30 = 0.80). For corti-
sol, the minimum detectable difference in
changes from baseline needed for a power of
90% was 0.066 µg/dL using a 0.05 signiﬁcance
level. The MCA condition resulted in a mean
decrease from baseline (the average baseline =
0.2627; SD = 0.1831) of 0.1148 µg/dL. Thus,
a decrease of no more than 0.0488 µg/dL 
in the VOC or VOC + O3 conditions was
needed to detect a difference. Finally, for lung
function, the minimum detectable differences
in changes from baseline are 109.7 mL,
122.8 mL, and 0.917 L/sec, respectively, for
changes in FEV1, FVC, and FEF25–75. These
were calculated with a signiﬁcance level of p =
0.0167 (0.05/3). Thus, for all dependent meas-
ures and the present sample size, relatively
small changes were needed to detect a differ-
ence between exposure conditions.
Conclusions
In conclusion, relatively brief, one-time expo-
sures to mixtures of VOCs or VOCs and their
oxidation products, at the upper bound of
typical indoor concentration range, did not
appear to cause significant acute changes in
symptoms, neurobehavioral performance, or
lung function in healthy women. In contrast,
the psychological stressor was effective in pro-
ducing increased autonomic arousal, as indi-
cated by salivary cortisol, and in causing
increased symptoms of anxiety, both well-
documented effects of psychological stress.
However, stress and exposure were neither
synergistic nor additive in their effects on
symptoms or neurobehavioral performance.
The effect of stress, however, was isolated to
symptoms of anxiety and did not generalize to
other more typical symptoms associated with
poor indoor air such as nasal irritation or
headache. Although the irritation potency of
complex and variable mixtures of VOCs and
their oxidation products in buildings is difﬁ-
cult to predict, reported air concentrations of
VOCs in buildings with poor indoor air qual-
ity are typically an order of magnitude lower
than the VOC concentrations used in this
study. Thus, our results suggest that the VOC
concentration alone may not be the most
salient factor to account for acute health com-
plaints. Our present results support the con-
clusion that 3-hr exposures to VOCs or to the
reaction products of VOCs and O3 at concen-
trations typically found in nonindustrial
buildings are unlikely to be a signiﬁcant cause
of acute health complaints or effects for most
occupants.
Several caveats need to be considered for
our present study. This study included the
largest number of subjects to date and inten-
tionally selected only women for study because
of their hypothesized vulnerability to report
indoor air quality symptoms. However, the
extent to which our results apply to indoor air
problems experienced in a work environment
with many other demands and chronic expo-
sures is problematic. Thus, the lack of health
effects observed may simply be a function of
the necessarily acute exposure paradigm with
healthy young subjects. Conversely, the expo-
sure concentrations were quantitatively higher
than those documented in most buildings
with indoor air complaints. Furthermore,
work demands were modeled in our study
through use of a known stressor as well as
requirements for computerized neuro-
behavioral tasks, and the former was successful
in causing autonomic arousal and symptoms 
of anxiety. Another attribute of our study was
that all exposure conditions were conducted at 
a relatively high air exchange rate (~ 1.8 air
exchanges/hr), whereas health complaints
associated with indoor air quality often occur
in buildings with poor ventilation (i.e., air
exchange rates were an order of magnitude
lower than the air exchange rate used in our
study). Overall, this study suggested that for a
2-hr time period, psychological stress may be a
more potent factor than ambient chemical
mixtures in the complaints attributed to poor
indoor environments.
Volatile organics, ozone, and stress
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Table 4. Effect sizes for symptom severity based on 130 subjects.
Change Total VOC Respiratory
(from 15 min) symptoma General Cognitive Eye Anxiety Upper Lower Somatic
60 min 0.99 2.69 2.48 2.07 1.43 1.42 0.74 1.04
125 min 1.15 2.98 2.69 2.15 1.85 1.49 0.64 1.13
aCalculated at a signiﬁcance level of 0.05. The effect sizes for all remaining subcategories of symptoms were calculated
at a signiﬁcance level of 0.05/7 = 0.0071.
Appendix 1. Symptom list.
VOC physical
Headache
Fatigue
Lightheaded
Drowsy
Nausea
VOC cognitive
Difﬁculty concentrating
Disoriented/confused
Dizzy
Eye irritation
Eye irritation (burning, dryness, or itching)
Runny/watery eyes
Anxiety
Feel jittery in body
Feel nervous
Heart palpitations
Feel tense
Worried
Upper respiratory
Sneeze
Nasal congestion
Choking
Throat irritation (burning or dryness)
Nose irritation, dryness, or itching
Lower respiratory
Short of breath
Wheezy
Chest tightening
Chest pain
Coughing
Somatic control
Skin irritation or dryness
Stomachache
Numbness/tingling
Ear ringing
Leg cramps
Back pain
Sweating
Body achesFiedler et al.
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